Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × durvalumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 17 Small Cell Lung Carcinoma 9 Urinary Bladder Neoplasms 7 Carcinoma, Hepatocellular 7 Neoplasms 6 Liver Neoplasms 5 Cholangiocarcinoma 5 Biliary Tract Neoplasms 5 Neoplasms by Site 3 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Stomach Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lung Diseases 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1

Interventions

Specimen Handling 4 Biopsy 4 Magnetic Resonance Spectroscopy 3 belinostat 2 X-Rays 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 pembrolizumab 1 cemiplimab 1 Whole-Body Irradiation 1 Spinal Puncture 1 Solutions 1 Photons 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 MEDI-570 1 Ipilimumab 1 Injections 1 Immunoglobulin G 1 Disulfides 1 CTLA-4 Antigen 1 Bendamustine Hydrochloride 1 Azacitidine 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡